logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
18/09/2025
Intel stock price soared 17%.
Latest
3 m ago
Yonghui Supermarket: Appoints Wang Shoucheng as Chief Executive Officer. He served as the head of the adjustment and reform team in the Yonghui Supermarket Donglai Learning Program.
3 m ago
Peak Technology (688279.SH) shareholder Shanghai Huaxin plans to reduce its shareholding by no more than 3%.
4 m ago
Ministry of Finance and other four departments issue a notice on further standardizing issues related to intellectual property asset evaluation.
5 m ago
Pre-market on Thursday, shares of pharmaceutical company Novo Nordisk (NVO) rose by 7.4% after announcing the results of its once-daily weight-loss drug late-stage trial. Novo Nordisk stated that the trial results showed that the drug achieved "significant" weight loss effects comparable to the company's injectable weight-loss drug Wegovy.
5 m ago
Before the opening of the U.S. stock market on Thursday, pharmaceutical company Novo Nordisk saw a 7.4% increase in its stock price after announcing the results of its once-daily weight loss drug late-stage trial. Novo Nordisk stated that the trial results showed that the drug achieved "significant" weight loss effects, comparable to the company's injectable weight loss drug Wegovy.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.